Stocktoria
CERUS CORP CERS
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1997-01-31
CERUS CORP financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $233.8M | $201.3M | $186.8M | $188.3M | $159.5M |
| SG&A expense | $80.9M | $75.9M | $75.5M | $83.3M | $81.3M |
| Operating income | -$8.7M | -$14.2M | -$30.1M | -$34.1M | -$48.9M |
| Interest expense | — | — | $8.4M | $5.8M | $4.9M |
| Income tax | $354,000 | $205,000 | $325,000 | $488,000 | $319,000 |
| Net income | -$15.6M | -$20.9M | -$37.5M | -$42.8M | -$54.4M |
| EPS (diluted) | $-0.08 | $-0.11 | $-0.21 | $-0.24 | $-0.32 |
| Operating cash flow | $4.8M | $11.4M | -$43.2M | -$25.6M | -$33.9M |
| Free cash flow | $1.1M | $8.5M | -$47.8M | -$27.6M | -$34.8M |
| Cash & equivalents | $20.0M | $20.3M | $11.6M | $35.6M | $48.8M |
| Inventory | $56.1M | $38.1M | $39.9M | $29.0M | $26.8M |
| Total assets | $221.9M | $200.9M | $197.7M | $218.1M | $237.5M |
| Total liabilities | $156.9M | $144.0M | $144.3M | $149.5M | $151.9M |
| Shareholders' equity | $65.0M | $56.9M | $53.4M | $68.6M | $85.6M |
Source: SEC EDGAR filings · CIK 0001020214 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.